Harvard Medical School, 25 Shattuck Street, Boston, MA 02115.
Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome
Article first published online: 19 AUG 2013
© 2013 The Authors. Journal of Medical Virology Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Journal of Medical Virology
Volume 85, Issue 12, pages 2101–2109, December 2013
How to Cite
Montoya, J. G., Kogelnik, A. M., Bhangoo, M., Lunn, M. R., Flamand, L., Merrihew, L. E., Watt, T., Kubo, J. T., Paik, J. and Desai, M. (2013), Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J. Med. Virol., 85: 2101–2109. doi: 10.1002/jmv.23713
The copyright line for this article was changed on 28 October 2015 after original online publication.
- Issue published online: 1 OCT 2013
- Article first published online: 19 AUG 2013
- Manuscript Accepted: 18 JUN 2013
- F. Hoffmann–La Roche (Basel, Switzerland)
- Stanford University School of Medicine Molecular Basis of Medicine Scholarly Concentration
- Stanford University School of Medicine Medical Scholars Fellowship Program
This article has been cited by:
- 1Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis, NeuroMolecular Medicine, 2015,,
- 2Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease, Medical Hypotheses, 2015, 85, 6, 765,